PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30637473-0	2019	STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes.	corosolic acid	83-97	CD163 molecule	Homo sapiens	68-73	
30637473-5	2019	Here, we report the first data on a CD163-targeted STAT3-inhibitory drug consisting of corosolic acid (CA) packaged within long-circulating liposomes (LCLs), which are CD163-targeted by modification with monoclonal anti-CD163 antibodies (alphaCD163)-CA-LCL-alphaCD163.	corosolic acid	87-101	CD163 molecule	Homo sapiens	36-41	
30637473-5	2019	Here, we report the first data on a CD163-targeted STAT3-inhibitory drug consisting of corosolic acid (CA) packaged within long-circulating liposomes (LCLs), which are CD163-targeted by modification with monoclonal anti-CD163 antibodies (alphaCD163)-CA-LCL-alphaCD163.	corosolic acid	87-101	CD163 molecule	Homo sapiens	168-173	
30637473-5	2019	Here, we report the first data on a CD163-targeted STAT3-inhibitory drug consisting of corosolic acid (CA) packaged within long-circulating liposomes (LCLs), which are CD163-targeted by modification with monoclonal anti-CD163 antibodies (alphaCD163)-CA-LCL-alphaCD163.	corosolic acid	87-101	CD163 molecule	Homo sapiens	168-173	
21073634-3	2011	Among 130 purified natural compounds examined, corosolic acid significantly inhibited the expression of CD163, one of the phenotype markers of M2 macrophages, and also suppressed the secretion of IL-10, one of the anti-inflammatory cytokines preferentially produced by M2 macrophages, thus suggesting that corosolic acid suppresses M2 polarization of macrophages.	corosolic acid	47-61	CD163 molecule	Homo sapiens	104-109